Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

ApoA-I(R151)Paris is a natural apolipoprotein (apo) A-I variant that is associated with low levels of high-density lipoprotein cholesterol (HDL-cholesterol) and the partial deficiency of lecithin:cholesterol acyl-transferase (LCAT) in the plasma of heterozygous carriers. We compared the abilities of recombinant normal apoA-I and recombinant apoA-I(R151C)Paris to clear an emulsion of dimyristoylphosphatidylcholine (DMPC), to form reconstituted lipoproteins with dipalmitoylphosphatidylcholine (DPPC), to activate LCAT, and to promote efflux of biosynthetic cholesterol from porcine aortic smooth muscle cells (SMCs) or of exogenous cholesterol from lipid-loaded mouse peritoneal macrophages. Recombinant apoA-I(R151C)Paris occurred in monomeric and dimeric forms at a ratio of 60:40. Normal apoA-I and apoA-I(R151C)Paris cleared DMPC emulsions at equal rates. Both isoforms associated completely with DPPC during cholate dialysis. Normal apoA-I formed one single particle with a mean diameter of 9.3 nm, whereas apoA-I(R151)Paris gave rise to three particles with mean diameters of 9.3 nm (containing 74% of apoA-I), 10.6 nm, and 12.1 nm, respectively. Compared to normal apoA-I, apoA-I(R151C)Paris had a reduced LCAT-cofactor activity with a 60% lower Vmax/Km ratio due to a 50% higher affinity constant, Km. During incubations for 10 min and 360 min, normal apoA-I/DPPC complexes and apoA-I(R151C)Paris/DPPC complexes were equally efficient in releasing biosynthetic cholesterol from SMCs. In the lipid-free form, apoA-I(R151C)Paris induced normal hydrolysis of cholesteryl esters and normal cholesterol efflux from lipid-loaded mouse-peritoneal macrophages. In conclusion, in addition to its ability to form homo- and heterodimers, apoA-I(R151C)Paris is characterized by defective LCAT-cofactor activity but by normal lipid binding and cholesterol-efflux-promoting abilities.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s001099900034DOI Listing

Publication Analysis

Top Keywords

normal apoa-i
16
lipid binding
8
reconstituted lipoproteins
8
cholesterol efflux
8
normal
8
recombinant apoa-ir151cparis
8
biosynthetic cholesterol
8
apoa-i apoa-ir151cparis
8
lcat-cofactor activity
8
cholesterol
7

Similar Publications

Topical lubricants are the fundamental treatment for dry eye disease (DED). However, the molecular mechanisms underlying their efficacy remain unknown. Here, the protective effects of Thealoz Duo with 3% trehalose and 0.

View Article and Find Full Text PDF

Self-association of Apolipoprotein A-I studied with multiple-association models: A pyrene multiparametric analysis.

Biochim Biophys Acta Proteins Proteom

August 2025

Instituto de Investigaciones Bioquímica de La Plata "Dr. Rodolfo R. Brenner" (INIBIOLP), Centro Científico Tecnológico-La Plata (CONICET), Calle 60 y 120 s/n, 1900 La Plata, Argentina; Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Calle 60 y 120 s/n, 1900 La Plata, Argentina. E

Apolipoprotein A-I (apoA-I) is the main protein of high-density lipoprotein particles, conferring anti-atherogenic properties through reverse cholesterol transport. In its lipid-free state, apoA-I self-associates, a process implicated in normal physiology as well as in pathological conditions, such as amyloidosis. Although various mechanisms have been proposed to explain its self-association, there is still no consensus, and its functional implications remain unclear.

View Article and Find Full Text PDF

Objective: This study aimed to elucidate the correlations among dyslipidemia, immune function, and clinical outcomes in patients with acute-on-chronic liver failure (ACLF), with particular emphasis on the clinical significance of lipid metabolism and cellular immune parameters in hepatitis B virus-associated ACLF (HBV-ACLF).

Methods: A retrospective analysis was conducted on 803 patients with HBV-ACLF admitted to the Shanghai Public Health Clinical Center from January 2014 to January 2024. Patients were stratified into deceased (n = 414) and survival (n = 389) groups based on clinical outcomes.

View Article and Find Full Text PDF

Objectives: This study aims to investigate the correlations between oxidized lipoproteins, specifically oxidized low-density lipoprotein (oxLDL) and oxidized high-density lipoprotein (oxHDL), and the comorbidities of T2DM and PTB (T2DM + PTB).

Methods: This prospective study included 360 cases from May 2022 to May 2023. The cohort consisted of 60 cases of pure hyperlipidemia, 100 cases of PTB, 100 cases of T2DM, and 100 cases of T2DM + PTB.

View Article and Find Full Text PDF

Network Pharmacology-Based Elucidation of the Hypoglycemic Mechanism of GF5000 Polysaccharides via GCK modulation in Diabetic Rats.

Nutrients

March 2025

National Health Commission Science and Technology Innovation Platform for Nutrition and Safety of Microbial Food, Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Guangdong Academy of Sciences,

Background/objectives: Our lab has previously reported that (maitake mushroom) GF5000 has antidiabetic potential owing to its ability to improve insulin resistance. This study aimed to gain insight into the system-level hypoglycemic mechanisms of GF5000 using transcriptomics, proteomics, and network pharmacology. This study provides new insights into the hypoglycemic mechanisms of GF5000, identifying key molecular targets involved in mitigating insulin resistance in T2DM.

View Article and Find Full Text PDF